ADGRL4 (Adhesion G Protein-Coupled Receptor L4, also known as ELTD1): ADGRL4 is implicated in angiogenesis and vascular development. It has been identified as a potential marker and therapeutic target in cancer due to its role in tumor vasculature. By regulating endothelial cell function and contributing to the formation of new blood vessels, ADGRL4 plays a crucial role in both physiological and pathological processes, including wound healing and cancer progression. Research aims to leverage ADGRL4's function for anti-angiogenic therapies in cancer treatment....